Profit180

15-May-2024 4:05 PM

Envoy Medical Reports First Quarter 2024 Results

The Company, a current leader in fully implanted hearing devices, continues to steadily march towards its ambition of disrupting the existing cochlear implant industry with its “breakthrough” fully implanted cochlear implant.

20-Apr-2024 1:00 PM

ROSEN, A LONGSTANDING LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , April 20, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

15-Apr-2024 1:36 PM

COCH LOSS ALERT: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , April 15, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

03-Apr-2024 5:13 PM

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , April 3, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

03-Apr-2024 8:05 AM

Envoy Medical to Participate in the LD Micro Invitational XIV Conference April 8 - 9, 2024

WHITE BEAR LAKE, Minnesota , April 03, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that Brent Lucas, Chief Executive Officer, and David R. Wells, Chief Financial Officer, will present a corporate overview at the LD Micro Invitational XIV 2024. The conference is being held on April 8 - 9, 2024 at the Sofitel Hotel in New York City.

02-Apr-2024 8:00 AM

Envoy Medical Reports Fourth Quarter and Full Year 2023 Financial Results

Company Provides Corporate Update that Include Updates on its Investigational Fully Implanted Acclaim® Cochlear Implant Meeting its Early Feasibility Study Milestones

24-Mar-2024 11:30 AM

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 24, 2024 /PRNewswire/ -- WHY: on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

17-Mar-2024 1:00 PM

COCH INVESTOR ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 17, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

12-Mar-2024 10:52 AM

Envoy Medical to Participate in the 36th Annual ROTH Conference

WHITE BEAR LAKE, Minnesota, March 12, 2024 (GLOBE NEWSWIRE) -- Envoy Medical®, Inc. (“Envoy Medical”) (Nasdaq: COCH), a revolutionary hearing health company focused on fully implanted hearing systems, today announced that it will participate in the 36th Annual ROTH Conference being held on March 17 – 19, 2024 at The Ritz Carlton, Laguna Niguel located in Dana Point, CA.

09-Mar-2024 5:15 PM

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Envoy Medical, Inc. Investors to Inquire About Securities Class Action Investigation - COCH

NEW YORK , March 9, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Envoy Medical, Inc. (NASDAQ: COCH) resulting from allegations that Envoy may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Envoy securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

04-Mar-2024 9:20 AM

Envoy Medical Secures Up To $10 Million Term Debt Financing to Advance Upcoming Clinical Trial

Billionaire Entrepreneur Glen Taylor Commits to a 5-Year Facility to Support Company's upcoming FDA Clinical Trial for the Acclaim® Fully Implanted Cochlear Implant

Symbol	COCH
Market Cap	60.9M
Price	3.11
Open	3.08
52-wk High	11.72
50 Day Avg	4.87
Earnings Announcement	2024-08-21
Website	https://www.envoymedical.com

Name	Envoy Medical, Inc.
Shares Outstanding	19,600,000
Change %	2.9801%
Low	3.08
52-wk Low	0.75
200 Day Avg	4.43
Last Dividend	0.00

Exchange	NASDAQ
Volume	45,743
Previous Close	3.02
High	3.42
EPS	-2.38
PE	-1.31
Avg Volume	453,616
CUSIP

Description	Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.
Currency	USD
ISIN	US29415V1098

Industry	Medical - Devices
Changes	0.09
CUSIP

Envoy Medical, Inc. Outlook

Envoy Medical, Inc. News